This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Robertson, S. A.
Right arrow Articles by Myers, M. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, S. A.
Right arrow Articles by Myers, M. G., Jr.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2009, p. 3367-3378, Vol. 29, No. 12
0270-7306/09/$08.00+0     doi:10.1128/MCB.00278-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Regulation of Jak2 Function by Phosphorylation of Tyr317 and Tyr637 during Cytokine Signaling{triangledown}

Scott A. Robertson,1,2 Rositsa I. Koleva,3 Lawrence S. Argetsinger,2 Christin Carter-Su,2 Jarrod A. Marto,3 Edward P. Feener,4 and Martin G. Myers Jr.1,2*

Departments of Internal Medicine,1 Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan 48109-5638,2 Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115,3 Harvard Medical School and Research Division, Joslin Diabetes Center, Boston, Massachusetts 021154

Received 3 March 2009/ Returned for modification 21 March 2009/ Accepted 31 March 2009

Jak2, the cognate tyrosine kinase for numerous cytokine receptors, undergoes multisite phosphorylation during cytokine stimulation. To understand the role of phosphorylation in Jak2 regulation, we used mass spectrometry to identify numerous Jak2 phosphorylation sites and characterize their significance for Jak2 function. Two sites outside of the tyrosine kinase domain, Tyr317 in the FERM domain and Tyr637 in the JH2 domain, exhibited strong regulation of Jak2 activity. Mutation of Tyr317 promotes increased Jak2 activity, and the phosphorylation of Tyr317 during cytokine signaling requires prior activation loop phosphorylation, which is consistent with a role for Tyr317 in the feedback inhibition of Jak2 kinase activity after receptor stimulation. Comparison to several previously identified regulatory phosphorylation sites on Jak2 revealed a dominant role for Tyr317 in the attenuation of Jak2 signaling. In contrast, mutation of Tyr637 decreased Jak2 signaling and activity and partially suppressed the activating JH2 V617F mutation, suggesting a role for Tyr637 phosphorylation in the release of JH2 domain-mediated suppression of Jak2 kinase activity during cytokine stimulation. The phosphorylation of Tyr317 and Tyr637 act in concert with other regulatory events to maintain appropriate control of Jak2 activity and cytokine signaling.

* Corresponding author. Mailing address: Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Medical School, 5560 MSRB II, MSP5678, 1150 W. Medical Center Dr., Ann Arbor, MI 48109. Phone: (734) 647-9515. Fax: (734) 936-6684. E-mail: mgmyers{at}umich.edu

{triangledown} Published ahead of print on 13 April 2009.

Molecular and Cellular Biology, June 2009, p. 3367-3378, Vol. 29, No. 12
0270-7306/09/$08.00+0     doi:10.1128/MCB.00278-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»